Phenotypic Variation in Hyperandrogenic Women Influences the Findings of Abnormal Metabolic and Cardiovascular Risk Parameters
Enrico Carmina(OHB (Italy)), Rogerio A. Løbo(Columbia University Irving Medical Center), Giovam Battista Rini(University of Palermo), Rosa Alba Longo(University of Palermo), Micheline C. Chu(Columbia University)
Cited by 274
Related Papers
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
|Fertility and Sterility|2011|2k
Polycystic ovary syndrome
|Nature Reviews Disease Primers|2016|1.9k
American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
|Endocrine Practice|2015|628
Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women
|The Journal of Clinical Endocrinology & Metabolism|1999|508